XNZW:XETRA:XETRA-Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 48.075

Change

+1.15 (+2.45)%

Market Cap

N/A

Volume

104.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.76%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.28 (+1.72%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.42 (+1.57%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.45 (+1.61%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.73%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.87 (+1.94%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+2.20 (+1.54%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.84 (+1.68%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.07 (+3.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+23.06 (+4.12%)

USD 80.38B

ETFs Containing XNZW:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.90% 78% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.90% 78% C+ 78% C+
Trailing 12 Months  
Capital Gain 27.86% 75% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.86% 75% C 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.79% 68% D+ 66% D+
Dividend Return 9.79% 67% D+ 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.33% 60% D- 68% D+
Risk Adjusted Return 94.78% 91% A- 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike